68 related articles for article (PubMed ID: 8545554)
1. [Calcitonin gene-related peptide in diabetes mellitus type 2: a possible etiopathogenetic role].
Parlapiano C; Minniti G; Primi F; Campana E
Riv Eur Sci Med Farmacol; 1995; 17(1):35-9. PubMed ID: 8545554
[TBL] [Abstract][Full Text] [Related]
2. CGRP and ET-1 plasma levels in normal subjects.
Parlapiano C; Paoletti V; Campana E; Giovanniello T; Pantone P; Labbadia G; Califano F; Donnarumma L; Musca A
Eur Rev Med Pharmacol Sci; 1999; 3(3):139-41. PubMed ID: 10827818
[TBL] [Abstract][Full Text] [Related]
3. The physiology of calcitonin gene-related peptide in the islet compared with that of islet amyloid polypeptide (amylin).
Bretherton-Watt D; Ghatei MA; Jamal H; Gilbey SG; Jones PM; Bloom SR
Ann N Y Acad Sci; 1992 Jun; 657():299-312. PubMed ID: 1637089
[TBL] [Abstract][Full Text] [Related]
4. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
Hrnciar J
Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
[TBL] [Abstract][Full Text] [Related]
5. Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide.
Molina JM; Cooper GJ; Leighton B; Olefsky JM
Diabetes; 1990 Feb; 39(2):260-5. PubMed ID: 2227135
[TBL] [Abstract][Full Text] [Related]
6. [Calcitonin gene-related peptide (CGRP)].
Raynaud A; Cohen R; Modigliani E
Presse Med; 1994 Feb; 23(4):171-5. PubMed ID: 8177860
[TBL] [Abstract][Full Text] [Related]
7. [Calcitonin gene-related peptide (CGRP): a vasodilator neuropeptide with many potential applications].
Grunenberger F
Pathol Biol (Paris); 1993 Dec; 41(10):936-42. PubMed ID: 8159474
[TBL] [Abstract][Full Text] [Related]
8. [Function of Perivascular Nerves in Insulin Resistance-induced Hypertension].
Takatori S
Yakugaku Zasshi; 2017; 137(11):1367-1371. PubMed ID: 29093373
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.
Leighton B; Cooper GJ
Nature; 1988 Oct; 335(6191):632-5. PubMed ID: 3050530
[TBL] [Abstract][Full Text] [Related]
10. Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.
Koopmans SJ; Radder JK; Krans HM; Barge RM
Neth J Med; 1992 Aug; 41(1-2):82-90. PubMed ID: 1407245
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
O'Brien TD; Butler PC; Westermark P; Johnson KH
Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
[TBL] [Abstract][Full Text] [Related]
12. [Role of amylin in the pathogenesis of type II diabetes mellitus].
Prager R; Ludvik B; Hartter E
Acta Med Austriaca; 1991; 18(3):61-2. PubMed ID: 1950379
[TBL] [Abstract][Full Text] [Related]
13. Targeted expression of the neuropeptide calcitonin gene-related peptide to beta cells prevents diabetes in NOD mice.
Khachatryan A; Guerder S; Palluault F; Cote G; Solimena M; Valentijn K; Millet I; Flavell RA; Vignery A
J Immunol; 1997 Feb; 158(3):1409-16. PubMed ID: 9013986
[TBL] [Abstract][Full Text] [Related]
14. Mechanism by which calcitonin gene-related peptide antagonizes insulin action in vivo.
Choi SB; Frontoni S; Rossetti L
Am J Physiol; 1991 Feb; 260(2 Pt 1):E321-5. PubMed ID: 1996634
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus decreases the expression of calcitonin-gene related peptide, gamma-amino butyric acid and glutamic acid decarboxylase in human pancreatic islet cells.
Al-Salam S; Hameed R; Parvez HS; Adeghate E
Neuro Endocrinol Lett; 2009; 30(4):506-10. PubMed ID: 20010500
[TBL] [Abstract][Full Text] [Related]
16. Decreased perivascular CGRP-containing nerves in Otsuka Long-Evans Tokushima Fatty rats with insulin resistance and hypertension.
Takatori S; Fujiwara H; Zamami Y; Hashikawa-Hobara N; Kawasaki H
Hypertens Res; 2014 May; 37(5):398-404. PubMed ID: 24225770
[TBL] [Abstract][Full Text] [Related]
17. The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors.
Charvat J; Svab P; Havlin J; Bilek R; Zamrazil V
Neuro Endocrinol Lett; 2014; 35(2):154-8. PubMed ID: 24878981
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide gene therapy suppresses reactive oxygen species in the pancreas and prevents mice from autoimmune diabetes.
She F; Sun W; Mao JM; Wang X
Sheng Li Xue Bao; 2003 Dec; 55(6):625-32. PubMed ID: 14695477
[TBL] [Abstract][Full Text] [Related]
19. Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor.
Kreutter DK; Orena SJ; Torchia AJ; Contillo LG; Andrews GC; Stevenson RW
Am J Physiol; 1993 Apr; 264(4 Pt 1):E606-13. PubMed ID: 8386456
[TBL] [Abstract][Full Text] [Related]
20. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans.
Jamal H; Jones PM; Byrne J; Suda K; Ghatei MA; Kanse SM; Bloom SR
Endocrinology; 1991 Dec; 129(6):3372-80. PubMed ID: 1954911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
